84892-275-99 : NDC 2026 Code

84892-275-99 : Carbachol And Brimonidine Tartrate ( Yuvezzi )

Additionally :

You can get information about “84892-275-99” NDC code in 84892-275-99 in HTML format

HTML | 84892-275-99 in TXT (Plain Text) format

TXT | 84892-275-99 in PDF (Portable Document Format)

PDF | 84892-275-99 in XML format

XML formats.

NDC Code : 84892-275-99 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "84892-275-99",
    "PackageDescription": "1 POUCH in 1 CARTON (84892-275-99)  / 5 VIAL, SINGLE-DOSE in 1 POUCH (84892-275-02)  / .16 mL in 1 VIAL, SINGLE-DOSE (84892-275-01) ",
    "NDC11Code": "84892-0275-99",
    "ProductNDC": "84892-275",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Yuvezzi",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Carbachol And Brimonidine Tartrate",
    "DosageFormName": "SOLUTION/ DROPS",
    "RouteName": "OPHTHALMIC",
    "StartMarketingDate": "20260218",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA220142",
    "LabelerName": "Visus Therapeutics, Inc.",
    "SubstanceName": "BRIMONIDINE TARTRATE; CARBACHOL",
    "StrengthNumber": "1; 27.5",
    "StrengthUnit": "mg/mL; mg/mL",
    "Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Cholinergic Agonists [MoA], Cholinergic Receptor Agonist [EPC], alpha-Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-02-20",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260218",
    "EndMarketingDatePackage": null,
    "SamplePackage": "Y"
  }
}